Effect of infliximab on experimentally induced otitis media in rats

Annals of Otology, Rhinology and Laryngology

Volumn 117, Issue 6, 2008, Pages 470-476

  Lee, Dong Hee ^a   Yeo, Sang Won ^a,b   Chang, Ki Hong ^a   Park, So Young ^a   Oh, Jeong Hoon ^a   Seo, Jae Hyun ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Anti inflammatory agent; Infliximab; Monoclonal antibody; Otitis media; Rat; Tumor necrosis factor

Indexed keywords

EVANS BLUE; INFLIXIMAB; ANTIINFLAMMATORY AGENT; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; MIDDLE EAR MUCOSA; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; ANIMAL; CAPILLARY PERMEABILITY; FLUORESCENCE MICROSCOPY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE EAR; MUCOSA; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CAPILLARY PERMEABILITY; EAR, MIDDLE; EVANS BLUE; INJECTIONS, INTRAVENOUS; MICROSCOPY, FLUORESCENCE; MUCOUS MEMBRANE; OTITIS MEDIA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 49849095286     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940811700611     Document Type: Article

References (13)

1. Weaver AL. Efficacy and safety of the anti-TNF biologic agents. Mod Rheumatol 2004;14:101-12.
2. Lee DH, Park YS, Jung TT, Yeo SW, Choi YC, Jeon E. Effect of tumor necrosis factor-alpha on experimental otitis media with effusion. Laryngoscope 2001;111:728-33.
3. Jeon EJ, Park YS, Choi YC, Yeo SW, Jung TT. Effect of inhibitor of tumor necrosis factor-alpha on experimental otitis media with effusion. Ann Otol Rhinol Laryngol 2001;110:917-21.
4. Park YS, Auo HJ, Jeon EJ, Chang KH, Lee SK, Lee DH. Effect of inhibitor of tumor necrosis factor-alpha and oxatomide on immune mediated otitis media. Laryngoscope 2006;116:1642-6.
5. Kim DH, Park YS, Jeon EJ, Yeo SW, Chang KH, Lee SK. Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. Ann Otol Rhinol Laryngol 2006;115:617-23.
6. Xu Q, Qaum T, Adamis AP. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 2001;42:789-94.
7. Zhang SX, Ma JX, Sima J, et al. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am J Pathol 2005;166:313-21.
8. Tomasek JJ, Haaksma CJ, Schwartz RJ, et al. Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci 2006;47:2693-700.
9. Schousboe LP, Ovesen T, Pedersen CB. Middle ear epithelium has inflammatory capacity. Acta Otolaryngol Suppl 2000;543:89-91.
10. Lin J, Haruta A, Kawano H, et al. Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis media. J Infect Dis 2000;182:882-7.
11. Kerschner JE, Meyer TK, Burrows A. Chinchilla middle ear epithelial mucin gene expression in response to inflammatory cytokines. Arch Otolaryngol Head Neck Surg 2004;130:1163-7.
12. Kawano H, Haruta A, Tsuboi Y, et al. Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: the pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol 2002;111:415-22.
13. Triantafillidis JK, Papalois AE, Parasi A, et al. Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. World J Gastroenterol 2005;11:6843-7.